ELV — Elevance Health, Inc.
—
NYSE ·
Financials ·
Insurance ·
CIK 1156039 ·
Last close
$399.14
Market Cap
$86.56B
52W High
$436.24
52W Low
$362.98
ADV30
1,408,458
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 50,474,000,000 | — | — | 1,463,000,000 | 126,438,000,000 | 10,232,000,000 | 81,416,000,000 |
| Mar 2026 | 50,181,000,000 | — | — | 1,764,000,000 | 125,827,000,000 | 9,657,000,000 | 81,785,000,000 |
| Dec 2025 | 49,747,000,000 | — | — | 547,000,000 | 121,494,000,000 | 9,491,000,000 | 77,468,000,000 |
| Sep 2025 | 50,711,000,000 | — | — | 1,189,000,000 | 122,749,000,000 | 8,713,000,000 | 78,667,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$7,464,000,000
Investing CF
$-2,243,000,000
Financing CF
$-3,530,000,000
CapEx
$-1,175,000,000
Dividends Paid
$-1,507,000,000
Buybacks
$-2,705,000,000
EPS Diluted TTM
$22.50
As of
2026-07-19
Balance + Analyst (yfinance extras)
Retained Earnings
$36,675,000,000
Inventory
—
Receivables
$23,392,000,000
ST Investments
$25,719,000,000
EBIT TTM
$7,300,000,000
Pretax Income TTM
$5,862,000,000
Interest Exp TTM
$1,438,000,000
Analysts
21
Yahoo Snapshot (yfinance, live)
Total Revenue
$201,113,993,216
EBITDA
$8,323,999,744
Free Cash Flow
$4,306,375,168
Enterprise Value
$80,230,211,584
Total Cash
$37,513,998,336
Total Debt
$31,043,999,744
Shares Out
216,869,290
Trailing EPS
$23.11
Book Value
$206.99
ROE
11.1%
ROA
3.8%
Div Yield
1.76%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 199,125,000,000 | — | 5,662,000,000 | 121,494,000,000 | 77,468,000,000 | — | 4,290,000,000 |
| Dec 2024 | 176,810,000,000 | — | 5,980,000,000 | 116,889,000,000 | 75,463,000,000 | — | 5,808,000,000 |
| Dec 2023 | 171,340,000,000 | — | 5,987,000,000 | 108,928,000,000 | 69,523,000,000 | — | 8,061,000,000 |
| Dec 2022 | 156,595,000,000 | — | 5,894,000,000 | 102,755,000,000 | 66,425,000,000 | — | 8,399,000,000 |
TTM Snapshot
Revenues TTM
$166,526,000,000
NetIncome TTM
$5,545,000,000
OpCashFlow TTM
$0
Assets (Latest)
$116,889,000,000
Forward EPS
$29.63
Max Pain — expiry 2026-08-21
max pain strike: $380.00 · spot: $398.22 · call oi: 3,674 · put oi: 2,063
Expected Move to 2026-08-21:
±$14.85
(3.73%) —
implied range
$383.37 –
$413.07
· ATM straddle on $400.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MRSH | MARSH & MCLENNAN COMPANIES, INC. | $90.13B | $188.86 | — |
| TRV | TRAVELERS COMPANIES, INC. | $77.21B | $370.16 | — |
| AON | Aon plc | $74.74B | $352.36 | — |
| CI | Cigna Group | $73.30B | $277.41 | — |
| MFC | MANULIFE FINANCIAL CORP | $72.64B | $43.78 | — |
News headlines (Yahoo Finance, 1h cache)
Is Elevance Health (ELV) Entering a Major Earnings Recovery?
2026-08-04 16:21 · Yahoo
Is Elevance Health (ELV) Positioned for Margin Recovery?
2026-08-04 15:25 · Yahoo
Elevance Health (ELV) After Its Cancer Care Push, Does The Valuation Still Look Attractive##
2026-08-01 09:12 · Yahoo
Elevance Health’s CEO started her career as a pro basketball player. Now she’s the highest‑ranking woman on the Global 500, leading a $199B giant
2026-07-31 07:00 · Yahoo
Carelon Research and Manifold Partner to Expand Real-World Evidence Access for Life Sciences Researchers
2026-08-11 11:30 · Yahoo
Can Humana Improve Caregiver Retention With HealthStream Deal?
2026-08-13 14:17 · Yahoo
Can UNH's Lower Medical Costs Sustain the Earnings Recovery?
2026-08-12 18:33 · Yahoo
UNH Leads Its Peer Group. You Pay For That
2026-08-07 20:40 · Yahoo
Encompass Health Beats Q2 Earnings Estimates, Raises '26 View
2026-08-07 15:47 · Yahoo
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
2026-08-06 17:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.